2016-2017 Funded Collaborations
International Collaborative Grants
Developing Novel Therapeutic Approaches For High Risk Acute Lymphoblastic Leukemia
|
| ||
| Hua E. Yu, Ph.D. Immuno-Oncology City of Hope | Shai Izraeli, M.D. Cancer Research Center Chaim Sheba Medical Center | ||
Characterization Of The Lung Cancer Microbiome And Its Effects On Response To Treatment
|
| ||
| Dan Raz, M.D. Surgery City of Hope | Ravid Straussman, M.D., Ph.D. Molecular Cell Biology Weizmann Institute of Science | ||
Spectrum Of Germline P53 And Somatic Genomic Variants In Israeli Breast Cancer Patients
|
| ||
| Jeffrey Weitzel, M.D. Population Sciences/Clinical Cancer Genetics City of Hope | Gad Rennert, M.D., Ph.D. Carmel Medical Center, Community Medicine and Epidemiology | ||
WWOX Loss Activates Aerobic Glycolysis In TNBC
|
| ||
| Victoria Seewaldt, M.D. Population Sciences| City of Hope | Rami Aqeilan, Ph.D. Lautenberg Center for Immunology and Cancer Research Hebrew University/Hadassah Medical School. | ||
Sabbatical
Distribution And Diffusion Of Nanoparticles In Tumoral Tissue
|
| ||
| Jacob Berlin, Ph.D. Molecular Medicine City of Hope | Abraham Domb, Ph.D. School of Pharmacy Hebrew University | ||
| About the Israel Cancer Research Fund Israel Cancer Research Fund, a 501(c)(3) organization, is the largest nationwide charitable organization in North America solely devoted to supporting cancer research in Israel. Since its establishment in 1975, ICRF has provided more than 2,200 grants to outstanding cancer researchers whose laboratories are located in all of the leading research institutions, universities and hospitals across Israel. For more information, visit www.icrfonline.org. |